Get started
MarketMoversReport

Intra-Cellular Therapies Announces FDA Approval of New Dosage

Long
Intra-Cellular Therapies Inc. (NASDAQ:ITCI)  
MarketMoversReport  
NASDAQ:ITCI   Intra-Cellular Therapies Inc.
Beyond Technical Analysis
0
0
beyondta
ITCI: Intra-Cellular Therapies Inc.
2022-04-25 07:00:00
Intra-Cellular Therapies Announces FDA Approval of New Dosage Strengths for CAPLYTA® (lumateperone) for Specific Patient Populations
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.